Stryker Corporation $SYK Shares Sold by First Manhattan CO. LLC.

First Manhattan CO. LLC. lessened its stake in Stryker Corporation (NYSE:SYK) by 8.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 66,412 shares of the medical technology company’s stock after selling 6,057 shares during the period. First Manhattan CO. LLC.’s holdings in Stryker were worth $23,400,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of SYK. Godfrey Financial Associates Inc. acquired a new position in shares of Stryker in the fourth quarter worth $26,000. United Financial Planning Group LLC acquired a new position in shares of Stryker in the third quarter worth $27,000. Atlas Capital Advisors Inc. acquired a new position in shares of Stryker in the fourth quarter worth $27,000. DJE Kapital AG acquired a new position in shares of Stryker in the fourth quarter worth $28,000. Finally, CGC Financial Services LLC acquired a new position in shares of Stryker in the fourth quarter worth $29,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 310,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total value of $96,791,300.00. Following the completion of the sale, the director directly owned 1,924,880 shares of the company’s stock, valued at $601,005,282.40. The trade was a 13.87% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Robert S. Fletcher sold 4,544 shares of the business’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total transaction of $1,394,417.28. Following the completion of the sale, the vice president directly owned 10,582 shares of the company’s stock, valued at approximately $3,247,298.34. This trade represents a 30.04% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 323,264 shares of company stock valued at $100,659,489 over the last ninety days. Insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

SYK has been the subject of several research reports. Needham & Company LLC dropped their price target on shares of Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Wall Street Zen downgraded shares of Stryker from a “buy” rating to a “hold” rating in a research note on Saturday, May 16th. Wells Fargo & Company dropped their price target on shares of Stryker from $456.00 to $418.00 and set an “overweight” rating for the company in a research note on Friday, May 1st. Robert W. Baird set a $385.00 price target on shares of Stryker in a research note on Friday, May 1st. Finally, William Blair restated an “outperform” rating on shares of Stryker in a research note on Thursday, March 5th. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $395.33.

Stryker Price Performance

Stryker stock opened at $301.24 on Thursday. The company has a fifty day simple moving average of $314.89 and a 200-day simple moving average of $342.38. The stock has a market cap of $115.48 billion, a P/E ratio of 34.87, a price-to-earnings-growth ratio of 1.99 and a beta of 0.78. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87. The company has a current ratio of 2.11, a quick ratio of 1.25 and a debt-to-equity ratio of 0.62.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion during the quarter, compared to analyst estimates of $6.34 billion. Stryker had a net margin of 13.20% and a return on equity of 23.42%. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period last year, the company earned $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Equities analysts expect that Stryker Corporation will post 14.98 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be given a $0.88 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.2%. Stryker’s payout ratio is 40.74%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.